M. Ali Nasseri | Medicine and Health Sciences | Innovative Research Award

Innovative Research Award

M. Ali Nasseri · Technical University of Munich · Germany

Researcher profile
M. Ali Nasseri
Affiliation Technical University of Munich
Country Germany
Scopus ID 55849349900
Documents 78
Citations 1,160
h-index 19
Subject area Medicine and Health Sciences
Event International Research Hypothesis Excellence Award
ORCID 0000-0002-9764-5731

Innovative Research Award is the title of this academic recognition profile concerning M. Ali Nasseri, whose supplied researcher information associates him with the Technical University of Munich in Germany and the subject area of Medicine and Health Sciences. The profile presents the bibliometric indicators provided for the researcher and outlines considerations relevant to evaluating research contributions in the context of the International Research Hypothesis Excellence Award. The information should be checked against authoritative researcher records before being used for formal recognition or bibliometric comparisons.[1][2]

Abstract

This article presents an academic recognition profile for M. Ali Nasseri in the context of the Innovative Research Award and the International Research Hypothesis Excellence Award. The supplied profile data lists 78 documents, 1,160 citations, and an h-index of 19, with Medicine and Health Sciences identified as the relevant subject area. These bibliometric values provide a quantitative starting point for describing research output and citation activity. However, the figures alone do not establish the originality, methodological quality, clinical relevance, or practical impact of individual studies. A comprehensive assessment would also require examination of verified publications, research methods, scholarly contributions, and independent evaluation criteria.[1][3]

Keywords

Innovative Research Award; M. Ali Nasseri; Medicine and Health Sciences; research evaluation; bibliometrics; citation analysis; h-index; scholarly publications; research impact; International Research Hypothesis Excellence Award; academic recognition; scientific innovation.

Introduction

Research recognition programs provide a framework for identifying and acknowledging scholarly contributions across scientific disciplines. In medicine and health sciences, meaningful evaluation can involve the originality of research questions, the robustness of study design, the reproducibility of findings, ethical research practices, and the potential contribution of results to clinical or public health knowledge. Bibliometric measures can support this process, but they should be interpreted alongside qualitative evidence and the context in which the research was produced.[3][4]

This profile organizes the supplied information about M. Ali Nasseri into a structured academic overview. It is intended as a presentation of researcher information and award-related considerations, rather than an independently verified biography or an announcement that an award has been granted. Researcher identities, institutional affiliations, publication records, and award outcomes should be confirmed through their respective authoritative sources before publication.

Research Profile

The supplied information identifies M. Ali Nasseri with the Technical University of Munich in Germany and associates the profile with Medicine and Health Sciences. It reports 78 documents, 1,160 citations, and an h-index of 19. These values are presented as user-provided figures and have not been independently verified for this article. Researcher databases may display different values depending on author disambiguation, database coverage, document types, citation-update dates, and profile-merging practices.[1][2]

The supplied ORCID identifier is 0000-0002-9764-5731. ORCID provides persistent researcher identifiers that can help distinguish scholars with similar names and connect them to their research outputs. An ORCID record may contain information entered by the researcher or added through authorized integrations; its contents should therefore be reviewed directly when verifying a person’s biography, affiliations, and publications.[2]

Research Contributions

Assessing a researcher’s contributions requires examining the substance of their scholarly work, including the questions investigated, the methods applied, the reliability of the findings, and the relevance of the results to the wider research community. In medicine and health sciences, additional considerations may include clinical significance, patient safety, ethical oversight, transparent reporting, and the extent to which findings can be reproduced or translated into practice.[3][4]

The supplied profile does not include a verified publication list, individual study titles, abstracts, or a detailed research statement. Accordingly, specific discoveries, clinical advances, inventions, or methodological innovations cannot be attributed to M. Ali Nasseri on the basis of the available information alone. A reliable account of research contributions should be prepared after reviewing the researcher’s verified publications and relevant supporting evidence.

Publications

The supplied Scopus profile information reports 78 documents. This figure is included as provided and should not be treated as a confirmed current total until the linked author record has been checked. A document count may include different publication types, and a researcher’s database profile may contain records that require author-level verification to distinguish their own work from that of other researchers with similar names.[1]

A publication list suitable for an academic recognition profile should include verified bibliographic details, such as author names, article title, journal or conference title, year of publication, volume and issue where applicable, page range or article number, and DOI when available. Publications should be selected for relevance and evidentiary value rather than solely for citation frequency. No individual publication titles or DOI identifiers have been supplied for this profile, so specific articles cannot be listed reliably here.

For additional verification, the researcher’s Scopus record and ORCID profile may be consulted through the external links below. The Scopus identifier in the supplied infobox is 55849349900, while the provided profile URL contains a different author identifier, 55322962400, in its displayed link text. This discrepancy should be resolved before publication to ensure that the correct author record is linked. The URL used in this article follows the identifier 55849349900 supplied for the profile.

Research Impact

The supplied bibliometric figures are 1,160 citations and an h-index of 19 across 78 documents. The h-index is a citation-based indicator that combines publication output with citation frequency: a value of 19 generally means that at least 19 indexed publications have each received at least 19 citations within the database and at the time of measurement. The indicator does not directly measure methodological quality, originality, societal value, or the clinical importance of research.[5]

Citation counts can vary across scholarly databases because each service indexes different journals, proceedings, books, and other research outputs. They can also change over time as new publications are indexed and citation records are updated. For a fair assessment, the database, retrieval date, author identity, and calculation method should be documented. Quantitative indicators should be interpreted alongside expert assessment and evidence of the researcher’s actual contributions.[3][5]

Research impact may extend beyond citations to include changes in professional practice, contributions to clinical guidance, data and software resources, interdisciplinary collaboration, public health outcomes, and knowledge dissemination. These dimensions require appropriate evidence and should not be inferred from citation metrics alone.

Award Suitability

The International Research Hypothesis Excellence Award is the event identified for this profile. The supplied information provides a basis for organizing the researcher’s stated bibliometric indicators within an academic recognition page. However, these figures alone are not sufficient to determine eligibility, establish award suitability, or confirm that the researcher has received an award.

A balanced evaluation for an innovative research award could consider the originality and significance of the research hypothesis, the quality of supporting evidence, methodological rigor, reproducibility, ethical compliance, publication record, contribution to the relevant field, and potential for advancing scientific understanding. Where applicable, reviewers may also consider translational relevance, interdisciplinary value, and documented benefits to health or society. These are general assessment considerations, not a claim about the event’s official criteria.[3][4]

Before a final award-related statement is published, the organizers’ official eligibility rules and evaluation procedures should be consulted. The candidate’s identity, affiliation, publication record, and supporting documentation should be verified, and any selection outcome should be reported only when confirmed by the award organizers. This approach distinguishes an informational research profile from a formal award announcement.

Conclusion

This academic profile summarizes the information supplied for M. Ali Nasseri, including the stated affiliation with the Technical University of Munich, the subject area of Medicine and Health Sciences, and the reported bibliometric figures of 78 documents, 1,160 citations, and an h-index of 19. These details provide a structured starting point for researcher identification and academic recognition. They should be confirmed against authoritative records before being treated as current or independently established facts.

A defensible assessment of innovative research requires more than publication and citation totals. Verified scholarly outputs, transparent methodology, originality, reproducibility, ethical standards, and demonstrable contributions to the field are important components of a comprehensive review. The profile should therefore be updated with verified publications, relevant DOI records, and confirmed award information as those details become available.

References

  1. Elsevier. (n.d.). Scopus Author Search and author profiles. Scopus. Consult the author record to verify the researcher’s identifier, indexed documents, citations, and h-index.
    https://www.scopus.com/
  2. ORCID. (n.d.). ORCID: Connecting research and researchers. ORCID provides persistent identifiers that help distinguish researchers and connect them with scholarly outputs.
    https://orcid.org/
  3. Hicks, D., Wouters, P., Waltman, L., de Rijcke, S., & Rafols, I. (2015). Bibliometrics: The Leiden Manifesto for research metrics. Nature, 520, 429–431.
    DOI: https://doi.org/10.1038/520429a
  4. San Francisco Declaration on Research Assessment (DORA). (2012; subsequent updates available). Declaration on Research Assessment. DORA advocates evaluating research on its merits and avoiding overreliance on journal-based metrics.
    https://sfdora.org/read/
  5. Hirsch, J. E. (2005). An index to quantify an individual’s scientific research output. Proceedings of the National Academy of Sciences, 102(46), 16569–16572.
    DOI: https://doi.org/10.1073/pnas.0507655102

Maria Szwajkowska | Medicine | Research Hypothesis Excellence Award

Dr. Maria Szwajkowska | Medicine | Research Hypothesis Excellence Award

Popowski Specialized Children’s Hospital | Poland

Dr. Maria Szwajkowska is a researcher in forensic medicine with expertise in trauma analysis and medico-legal case evaluation. Her research focuses on rare injury patterns, particularly craniofacial trauma and orbital region damage, contributing to improved forensic interpretation. With an academic background in medical and forensic sciences, she contributes to case-based research and clinical documentation. Her work reflects an emerging research profile grounded in clinical observation. Her approach emphasizes detailed case analysis, interdisciplinary collaboration, and evidence-based reporting, supporting advancements in forensic diagnostics and contributing to accurate legal and medical assessments.

View Orcid Profile

Featured Publications

 

Bruno Songel Sanchis | Medicine and Health Sciences | Best Review Paper Award

Bruno Songel Sanchis | Medicine and Health Sciences | Best Review Paper Award

Mr Bruno Songel Sanchis, Hospital clínico San Carlos, Spain

Mr. Bruno Songel Sanchis 🎻👓 is a versatile professional with dual expertise in music and vision sciences. Holding a Master’s in Optometry and Vision Sciences from the Complutense University of Madrid 🎓, and a degree in Optics and Optometry from the University of Valencia, he seamlessly combines clinical acumen with research innovation. His extensive clinical experience spans Hospital Clínico San Carlos and Fundación Salud Visual, focusing on cutting-edge myopia control, glaucoma diagnostics, and AI integration in ophthalmology 🤖🧠. Beyond clinics, Bruno’s passion for community service is evident through his impactful volunteer roles and outreach projects 🫶. A talented cellist 🎶 and a committed scientist, he bridges the gap between art and science with grace and dedication. His systematic review on ocular manifestations in IBD showcases his research depth 📄📊. A creative thinker and empathetic clinician, Bruno is a promising contender for the Best Review Paper Award 🥇🧬.

Publication Profile

Orcid

Education

Bruno Songel Sanchis has a rich and interdisciplinary educational background 🎓✨. He earned his Professional Degree in Music (Violoncello) from the Professional Music Conservatory of Valencia 🎻, showcasing his artistic talents. He later pursued a Scientific Baccalaureate at San José de Calasanz High School 🧪📘. Bruno’s scientific journey led him to the University of Valencia, where he obtained his Degree in Optics and Optometry 👁️📐. Committed to advancing vision care, he continued with a Master’s Degree in Optometry and Vision Sciences at the prestigious Complutense University of Madrid 👓🔬. He’s currently engaged in Project Efficiency Boost (2025–present), enhancing clinical productivity through AI and innovation 🚀🤖. His academic versatility reflects both analytical rigor and creativity, a rare blend that empowers his impactful work in clinical practice and scientific research 🧠📚.

Experience

Bruno has extensive hands-on experience in both clinical and research settings 🏥🔬. He served as a Clinical Optometrist at Hospital Clínico San Carlos (Madrid), rotating across subspecialties like myopia, retina, glaucoma, and cataracts 👁️💉. He contributed to pivotal research on myopia control with Atropine and later as a Clinical Research Technician at IdISSC, focused on the ‘LYDIA project’ developing AI diagnostic tools 🤖📊. His role as a Product Specialist marked a major milestone—implementing Europe’s first AI-powered ophthalmic imaging system at La Paz Hospital 🏥✨. Earlier, he worked at Óptica Universitaria and Alain Afflelou, gaining practical skills in optometry, sales, and customer care 🛠️🛍️. Bruno also holds a current role at Fundación Salud Visual (Funsavi), continuing his clinical contributions while mentoring others. These experiences shape him into a well-rounded professional with deep clinical knowledge, technical skills, and patient-centered care focus 👓🫶.

Awards and Honors

Bruno Songel Sanchis has garnered multiple honors for both creativity and scientific excellence 🏆📚. He won 1st prize in the UV Creative Outreach Project (2021) for innovative public science engagement 🎨💡. At the UVemprén Startup – Crea Awards, he secured 3rd position for his entrepreneurial vision in healthcare 🔬🚀. His musical talents earned him an Honorable Mention Diploma at an International Music Seminar, reflecting his multifaceted abilities 🎶🏅. He was also a Finalist in the MOTIVEM UV Awards, acknowledging his academic initiative and leadership 📘👏. As a Rapporteur at the SIYO 2022 Congress for Young Optometrists, he showcased his ability to bridge science and communication 🗣️📊. His certifications from the London School of Hygiene and Tropical Medicine in public health ophthalmology further validate his global competence in preventing blindness and tackling ocular diseases on an international level 🌍👁️.

Research Focus

Bruno Songel Sanchis’s research focuses on clinical optometry, ocular disease prevention, and artificial intelligence applications in ophthalmology 🧠👁️🤖. His major interests include myopia control, particularly using Atropine-based treatments, and early detection of age-related macular degeneration and glaucoma through AI-powered diagnostic systems 🧬📈. In collaboration with top-tier hospitals and research institutions, Bruno played a pivotal role in developing multi-diagnostic tools and conducting clinical trials on visual pathologies. His review on ocular extraintestinal manifestations in inflammatory bowel disease (IBD) offers critical insights into interdisciplinary patient care 📄🩺. A blend of practical clinical work and technical innovation defines his approach, with the goal of improving accessibility and effectiveness of vision care globally 🌐✨. His ongoing contributions to AI integration, coupled with community eye health initiatives, make him a forward-thinking optometrist and researcher committed to impactful, data-driven healthcare advancements 🩻📊.

Publication Top Notes

Analysis of the Incidence of Ocular Extraintestinal Manifestations in Inflammatory Bowel Disease Patients: A Systematic Review (2024)

 

Jonathan Trent | Medicine and Health Sciences | Lifetime achievement Award

Jonathan Trent | Medicine and Health Sciences | Lifetime achievement Award

Prof. Dr Jonathan Trent, Sylvester Comprehensive Cancer Center, University of Miami, United States

Prof. Dr. Jonathan Trent is a distinguished oncologist and researcher, specializing in sarcoma and precision medicine. With an MD and PhD from The University of Texas Health Science Center, he has dedicated his career to advancing cancer treatment. As Associate Director of Clinical Research at Sylvester Comprehensive Cancer Center, he leads groundbreaking studies in medical oncology. His leadership in precision medicine has transformed sarcoma treatment strategies. A prolific author, he has contributed to numerous high-impact publications, shaping the future of cancer therapy. Recognized for his mentorship and excellence in patient care, he has received prestigious awards like Sylvester Outstanding Mentor of the Year. His commitment to clinical innovation and translational research continues to impact oncology worldwide.

Publication Profile

Scopus

Education

Prof. Dr. Jonathan Trent earned his BS in 1988 from Southeastern Oklahoma State University, Durant, OK. He then pursued an MD-PhD program at The University of Texas Health Science Center, Houston, TX (1988-1995), where he developed expertise in oncology and medical research. His postgraduate training includes a Clinical Internship (1995-1996) and a Clinical Residency (1997-1999) at the same institution. He further specialized in cancer treatment through a Medical Oncology Fellowship at MD Anderson Cancer Center (1999-2002), where he also served as Chief Fellow. His extensive academic training laid a strong foundation for his groundbreaking research in sarcoma and precision medicine.

Experience

Prof. Dr. Jonathan Trent began his academic career as Assistant Professor (2002-2008) and later Associate Professor (2008-2011) at MD Anderson Cancer Center. He also served as an Adjunct Professor (2014-2015) at its Graduate School of Biomedical Sciences. Since 2013, he has been a Professor of Medicine at the University of Miami, where he is also Associate Director of Clinical Research, Director of the Sarcoma Medical Research Program, and Director of Precision Medicine at Sylvester Comprehensive Cancer Center. His leadership in sarcoma research, clinical trials, and precision oncology has significantly advanced cancer treatment.

Awards and Honors

Prof. Dr. Jonathan Trent has received numerous prestigious awards for his contributions to oncology, including the Sylvester Outstanding Mentor of the Year 🏆 (Miller School of Medicine, 2015), the Outstanding Care Award 🏅 (Sarcoma Alliance, 2012), and the Leadership in Clinical Research 🎖️ (Sylvester Comprehensive Cancer Center). He is an esteemed member of elite professional organizations such as the American Society for Clinical Oncology (ASCO), the American Association of Cancer Research (AACR), and The Max Foundation. His dedication to oncology research and patient care has earned him national and international recognition.

Research Focus

Prof. Dr. Jonathan Trent’s research focuses on sarcoma, targeted therapies, and precision oncology. He has played a pivotal role in the development of novel therapies, including TRK fusion inhibitors, CDK7-targeted treatments, and IDH1 mutation-based interventions. His work has significantly improved the understanding of leiomyosarcoma, chondrosarcoma, and desmoid tumors. As Director of Sarcoma Medical Research and Precision Medicine at Sylvester Comprehensive Cancer Center, he integrates genomic profiling and personalized treatment strategies to enhance patient outcomes. His extensive clinical trials and translational research have shaped modern sarcoma therapies, contributing to groundbreaking advancements in oncology.

Publication Top Notes

A Phase I Study of FHD-609, a Heterobifunctional Degrader of Bromodomain-Containing Protein 9, in Patients with Advanced Synovial Sarcoma or SMARCB1-Deficient Tumors

Gastrointestinal Stromal Tumor Patients with Molecular Testing Exhibit Superior Survival Compared to Patients without Testing: Results from the Life Raft Group (LRG) Registry

Beyond the Driver Mutation: Immunotherapies in Gastrointestinal Stromal Tumors

Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA

Notch pathway inhibition with LY3039478 in soft tissue sarcoma and gastrointestinal stromal tumours

Use of tyrosine kinase inhibitors in patients with GI stromal tumor who are pregnant or considering pregnancy: Driver mutations and circulating tumor DNA

Limb-sparing surgery plus radiotherapy results in superior survival: an analysis of patients with high-grade, extremity soft-tissue sarcoma from the NCDB and SEER